DuoNovo: How Long-Read Sequencing Can Improve Access to Genetic Testing

Empowered Patients Start with Better Education

Leading the Shift to Proactive Care: The Christ Hospital’s High‑Risk Program Strategy
Post Image

Hereditary Cancer Testing Menu Enhancements–May 2026
  • Lauren Csukardi
  • May 19, 2026

Our latest hereditary cancer menu enhancements are now available!   Ambry is dedicated to the search for new, evidence-backed insights that can meaningfully impact patient care. Our latest findings include additional evidence for MLH3, which has resulted in an upgraded gene-disease validity (GDV) for autosomal recessive polyposis …

Read More
Post Image

The Gene Scene: RYR2

  • May 19, 2026
Post Image

DuoNovo: How Long-Read Sequencing Can Improve Access to Genetic Testing

  • May 13, 2026
Post Image

The Gene Scene: SDHB

  • May 12, 2026
Post Image

The Gene Scene: MYBPC3

  • May 5, 2026
Post Image

The Power of Progress: Philip's NF1 Clinical Trial Experience
  • Meagan Farmer
  • May 22, 2024

We had the opportunity to connect with Renie and Philip Moss ahead of Neurofibromatosis Awareness Month. Philip has neurofibromatosis type 1 (NF1). It is associated with many features but most often causes growths called neurofibromas (usually benign) as well as characteristic skin and eye findings.1 Malignant or cancerous tumors are rare.1 You …

Read More
Post Image

Navigating NF1: The Moss Family’s Story of Resilience and Hope

  • May 16, 2024
Post Image

Transforming Fear into Action and Advocacy: Our Family’s Lynch Syndrome Story

  • March 22, 2024
Post Image

Peace of Mind: Michelle Majewski Trusts the Patient for Life Program to Share Answers for Her Son Owen

  • November 14, 2023
Post Image

Passing on a Legacy of Health: Ben Huebsch Shares His BRCA Story for Men’s Health Week

  • June 14, 2023

Subscribe

Subscribe to our blog for updates, sent out every month.

Tags